New vaginal device aims to ease Menopause-Linked discomfort
NCT ID NCT07367061
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called INNEA AQUA, used in the vagina, to see if it safely reduces symptoms of vulvo-vaginal atrophy (VVA) in adult women. VVA can cause itching, soreness, and pain during sex. The trial compares the device to standard care in 62 women aged 18-75. Researchers are tracking side effects and symptom changes over 120 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Innea Aqua (a vaginal device)
- What this could lead to
- If it works, this could offer a new option to ease symptoms like itching, soreness, and pain during sex for women with vulvo-vaginal atrophy.
- What could go wrong
- This is a small, early-stage trial with only 62 participants, so results may not apply to everyone. The device may not work better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVO VAGINAL ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMCA Medical Clinic
Bucharest, Romania, 030863, Romania
-
Nicolae Malaxa Clinical Hospital
Bucharest, Romania, 022441, Romania
-
Obstretics and Gynaecology Filantropia Clinical Hospital
Bucharest, Romania, 011132, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.